Activated invariant NKT cells regulate osteoclast development and function.

Activated invariant NKT cells regulate osteoclast development and function.

Invariant NKT (iNKT) cells modulate innate and adaptive immune responses through activation of myeloid dendritic cells and macrophages and via enhanced clonogenicity, differentiation, and egress of their shared myeloid progenitors. Because these same progenitors give rise to osteoclasts (OCs), which...

Full description

Bibliographic Details
Main Authors:	Hu, M, Bassett, J, Danks, L, Howell, P, Xu, K, Spanoudakis, E, Kotsianidis, I, Boyde, A, Williams, G, Horwood, N, Roberts, I, Karadimitris, A
Format:	Journal article
Language:	English
Published:	American Association of Immunologists 2011

Similar Items

Invariant NKT Cells Regulate Osteoclast Development and Function Under Homeostatic and during Conditions of Immune Activation
by: Hu, M, et al.
Published: (2008)

Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells.
by: Kotsianidis, I, et al.
Published: (2006)

Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells.
by: Kotsianidis, I, et al.
Published: (2005)

Human invariant NKT cells are required for effective in vitro alloresponses.
by: Patterson, S, et al.
Published: (2005)

Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors
by: Patterson, S, et al.
Published: (2008)

Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors.
by: Patterson, S, et al.
Published: (2008)

Expression of Bruton's tyrosine kinase in osteoclasts
by: Danks, L, et al.
Published: (2005)

Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1D interaction and killer immunoglobulin receptors
by: Patterson, S, et al.
Published: (2008)

Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids
by: Xu, K, et al.
Published: (2009)

Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease
by: Ersek, A, et al.
Published: (2015)

Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease
by: Anastasios Karadimitris, et al.
Published: (2019-06-01)

Description of invariant NKT cells.
by: Katarzyna Karwicka, et al.
Published: (2021-09-01)

Lack of Bruton's tyrosine kinase results in osteoporosis, despite defects in osteoclast function
by: Danks, L, et al.
Published: (2007)

The Tec kinases: Bmx and Btk play distinct regulatory roles in osteoclast differentiation
by: Danks, L, et al.
Published: (2005)

NK cells support osteoclast formation in vitro
by: Danks, L, et al.
Published: (2005)

Elevated cytokine production restores bone resorption by human Btk-deficient osteoclasts.
by: Danks, L, et al.
Published: (2011)

NK cells support osteoclast formation in vitro
by: Owen, S, et al.
Published: (2004)

Characterization and Functional Analysis of Mouse Invariant Natural T (iNKT) Cells
by: Bezbradica, J, et al.
Published: (2006)

Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo.
by: Felix Scheuplein, et al.
Published: (2015-01-01)

Harnessing invariant NKT cells in vaccination strategies.
by: Cerundolo, V, et al.
Published: (2009)

NK, NKT and Invariant-NKT Cells in Tumor Draining Lymph Nodes of Patients with Breast Cancer
by: Somayeh Rezaeifard, et al.
Published: (2019-12-01)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
by: Benjamin J. Wolf, et al.
Published: (2018-03-01)

Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis.
by: Amanda C Stanley, et al.
Published: (2008-02-01)

Reduced bone density in XLA patients, an effect of B cell deficiency on osteoclast differentiation and osteolytic activity
by: Danks, L, et al.
Published: (2008)

Reduced bone density in XLA patients, an effect of b-cell deficiency on osteoclast differentiation and osteolytic activity
by: Danks, L, et al.
Published: (2008)

Essential role for autophagy during invariant NKT cell development
by: Salio, M, et al.
Published: (2014)

Human CD4- invariant NKT lymphocytes regulate graft versus host disease
by: Tereza Coman, et al.
Published: (2018-11-01)

Invariant NKT Cell at the Interface between Innate and Adaptive Immunity
by: Salio, M, et al.
Published: (2011)

The role of invariant NKT cells at the interface of innate and adaptive immunity
by: Cerundolo, V
Published: (2010)

The role of invariant NKT cells at the interface of innate and adaptive immunity.
by: Cerundolo, V, et al.
Published: (2010)

Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants.
by: Reddy, BG, et al.
Published: (2009)

Invariant NKT cell response to dengue virus infection in human.
by: Ponpan Matangkasombut, et al.
Published: (2014-06-01)

Osteoclast defects in XLA patients are negated by lack of mature B cells and elevated inflammatory cytokine production
by: Danks, L, et al.
Published: (2009)

Osteoclast defects in XLA patients are negated by the lack of mature B cells and elevated inflammatory cytokine production
by: Danks, L, et al.
Published: (2009)

Osteoclast activity regulates the size of the haematopoietic stem cell pool
by: Ersek, A, et al.
Published: (2011)

Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells.
by: Hermans, I, et al.
Published: (2007)

Osteoclast Function Is Essential in the Hematopoietic Stem Cell Niche
by: Lymperi, S, et al.
Published: (2008)

Harnessing invariant NKT-cells to enhance antigen specific immune responses
by: Cerundolo, V
Published: (2014)

The complement system and invariant natural killer T (iNKT) cell responses
by: Malik, N
Published: (2021)

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses
by: Shin-ichiro Fujii, et al.
Published: (2018-06-01)